ICAM1 and colorectal carcinoma: Upregulation of ICAM-1 in CRC cells could increase cytotoxic lymphocytes (CTLs) infiltration and the expression of cytolytic immune effector molecules in the TME, which is associated with favorable prognosis in CRC (4, 28–30).